国際個別化医療学会

国際個別化医療学会誌

Personalized Medicine Universe®
Vo.7, July 2018

Personalized medicine for connective tissue disease: Historical and future perspectives

M. Kuwana

Cloning and expansion of antigen-specific T cells using iPS cell technology: Possible use of regenerated T cells in personalized medicine

H. Kawamoto, K. Masuda, S. Nagano

Significance of humanized mouse models for evaluating humoral immune response against cancer vaccines

Y. Kametani, A. Miyamoto, T. Seki, R. Ito, S. Habu, Y. Tokuda

Association of MTHF 677TT with adverse drug reactions and RFC G80A with non-response and adverse drug reactions in methotrexate therapy

M. M. AlSabbagh

Assessing antitumor and T cell immune responses by cytokine assay in cancer patients treated with immunotherapy – A pilot study

A. Morokuma, Y. Saeki, A. Nakamura, H. Sakuma, Y. Ishihara, M. Abe

Predictive factors for the development of bronchial asthma by the age of 3

N. Kondo, E. Matsui, T. Teramoto, M. Kuwabara, T. Nagata, Y. Furuta, M. Sanada, Ikuko Aoki, M. Kumada

Current state and issues related to cell therapy under the Act on the Safety of Regenerative Medicine

M. Tobita

Novel biologic products and Post-Bio strategy

K. Nishioka